Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy?

Diabetologia. 1996 Nov;39(11):1405-6. doi: 10.1007/s001250050591.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Complications*
  • Diabetic Angiopathies / drug therapy*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Peripheral Vascular Diseases / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin